Page 2 - Brief Visuospatial Memory Test Revised News Today : Breaking News, Live Updates & Top Stories | Vimarsana

4.7
(12)
Mayzent (siponimod) significantly improved cognitive processing speed in people with secondary progressive multiple sclerosis (SPMS) compared with a placebo, according to additional analyses of two-year data from the EXPAND Phase 3 trial.
While no approved therapies in the U.S. currently target cognitive impairment in MS, “our study found that [Mayzent], which is prescribed to slow the progression of physical disability in MS, may also help improve cognitive processing speed in people with advanced MS,” Ralph H. B. Benedict, PhD, the study’s first author, said in a press release.
Benedict is a professor of neurology at the University of Buffalo in New York, and a member of the American Academy of Neurology.  ....

New York , United States , Ralph Hb Benedict , Marta Figueiredo , University Of Buffalo , University Of Lisbon , Leiden University Medical Center , American Academy Of Neurology , Biomedical Sciences , American Academy , Symbol Digit Modalities Test , Paced Auditory Serial Addition Test , Brief Visuospatial Memory Test Revised , Developmental Biology , Medical Microbiology , Infectious Diseases , Applied Biology , Instituto De Medicina Molecular , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ரால்ப் ஹ்ப் பெனடிக்ட் , மார்த்தா பிகுேய்ரேதோ , பல்கலைக்கழகம் ஆஃப் எருமை , பல்கலைக்கழகம் ஆஃப் லிஸ்பன் , அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் , உயிர் மருத்துவ அறிவியல் ,